Middle East and Africa Cannabis Testing Market Research Report - Segmented By Product & Software, Testing Procedures, End-User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis From 2026 to 2034
The Middle East and Africa cannabis testing market size was valued at USD 102.11 million in 2025 and is anticipated to reach USD 115.49 million in 2026 from USD 309.20 million by 2034, growing at a CAGR of 13.1% during the forecast period from 2026 to 2034.
Cannabis a banned for various social and political reasons in most countries since the early 1900s. Many countries are now recognizing the benefits of cannabis for medical purposes and have approved its use of cannabis. The growth of the cannabis testing market in the MEA is majorly driven by factors such as the legalization of medical marijuana, an increase in marijuana labs (particularly in the United States), and increased use of LIMS in marijuana labs, conferences, and discussions. Awareness-raising meetings and workshops are expected to create the need for analytical testing to ensure the safety of human food and the growth of the MEA cannabis testing market.
In the MEA Cannabis Testing Market, highly developed industries and a variety of mature emerging areas are creating various market opportunities. Also, mergers & acquisitions, partnerships, contracts, agreements, new product launches, etc., by key players to gain a competitive edge over other companies can help increase market demand. In addition, the increased demand for medicines and therapeutic cannabis will likely expand market growth during the forecast period.
The high cost of analytical instruments, the presence of alternative technologies, and the lack of skilled professionals are critical factors that are supposed to limit the growth of the MEA Cannabis Testing Market in the future. Proper use of advanced analytical instruments requires relevant experience and knowledge of chromatography, spectroscopy, and PCR. In addition, the lack of awareness of the right technology choice, especially in emerging economies, has created many other indirect costs, increasing the workload and time pressure on researchers. This limits the use of these technically advanced products in the laboratory. Also, the laboratories are expensive to start, and analytical equipment is costly.
Geographically, the Middle East and African cannabis testing markets are still nascent in this region. However, factors such as the rising number of accidents under the influence of cannabis and its legalization for medical purposes in some parts of the world are expected to increase the growth of this market in the region.
A few of the prominent companies operating in the MEA cannabis testing market include
This research report on the MEA cannabis testing market has been segmented and sub-segmented into the following categories.
By Testing Procedures
By End-user
By Product & Software
By Country
Frequently Asked Questions
The MEA cannabis testing market size is estimated to be worth USD 273.38 million by 2033.
Factors such as increasing demand for cannabis products, the growing awareness about the importance of cannabis testing, the increasing legalization of cannabis, and the rising trend of self-medication are driving the MEA cannabis testing market.
Eurofins Scientific SE, Steep Hill, Inc., Agilent Technologies, Inc., Shimadzu Corporation, and CannaSafe Analytics are some of the key players in the MEA cannabis testing market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region